USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER'S DISEASE

摘要

The present invention relates to the use of antibodies against the CD52 antigen, specifically monoclonal antibodies, for the production of medicaments for the treatment of diseases of the central nervous system, in particular transmissible spongiform encephalopathies, diseases that are also called prion diseases.